Consulting Services
Compare Stocks
5 / 10Stock Comparison
FORR vs CSGP vs VRSK vs IT vs MSCI
Revenue, margins, valuation, and 5-year total return — side by side.
Real Estate - Services
Consulting Services
Information Technology Services
Financial - Data & Stock Exchanges
FORR vs CSGP vs VRSK vs IT vs MSCI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Consulting Services | Real Estate - Services | Consulting Services | Information Technology Services | Financial - Data & Stock Exchanges |
| Market Cap | $125M | $14.83B | $22.89B | $10.57B | $42.83B |
| Revenue (TTM) | $397M | $3.41B | $3.10B | $6.47B | $3.13B |
| Net Income (TTM) | $-119M | $25M | $910M | $741M | $1.32B |
| Gross Margin | 64.6% | 77.4% | 67.4% | 68.2% | 82.4% |
| Operating Margin | -20.9% | -0.8% | 44.9% | 16.4% | 54.7% |
| Forward P/E | 8.5x | 25.8x | 22.9x | 11.9x | 30.0x |
| Total Debt | $72M | $1.14B | $5.04B | $3.62B | $6.31B |
| Cash & Equiv. | $63M | $1.73B | $2.18B | $1.72B | $515M |
FORR vs CSGP vs VRSK vs IT vs MSCI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Forrester Research,… (FORR) | 100 | 20.8 | -79.2% |
| CoStar Group, Inc. (CSGP) | 100 | 53.3 | -46.7% |
| Verisk Analytics, I… (VRSK) | 100 | 101.2 | +1.2% |
| Gartner, Inc. (IT) | 100 | 129.7 | +29.7% |
| MSCI Inc. (MSCI) | 100 | 178.9 | +78.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORR vs CSGP vs VRSK vs IT vs MSCI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FORR is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (8.5x vs 30.0x)
CSGP ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
- Lower volatility, beta 0.80, Low D/E 13.7%, current ratio 2.84x
- 18.7% FFO/revenue growth vs FORR's -8.2%
VRSK lags the leaders in this set but could rank higher in a more targeted comparison.
IT is the clearest fit if your priority is valuation efficiency.
- PEG 0.45 vs VRSK's 2.68
MSCI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 11 yrs, beta 0.61, yield 1.2%
- 7.2% 10Y total return vs VRSK's 137.1%
- Beta 0.61, yield 1.2%, current ratio 0.90x
- 38.4% margin vs FORR's -30.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs FORR's -8.2% | |
| Value | Lower P/E (8.5x vs 30.0x) | |
| Quality / Margins | 38.4% margin vs FORR's -30.1% | |
| Stability / Safety | Beta 0.61 vs IT's 0.94 | |
| Dividends | 1.2% yield, 11-year raise streak, vs VRSK's 1.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +7.8% vs IT's -63.9% | |
| Efficiency (ROA) | 24.0% ROA vs FORR's -28.2%, ROIC 34.9% vs 0.8% |
FORR vs CSGP vs VRSK vs IT vs MSCI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FORR vs CSGP vs VRSK vs IT vs MSCI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 4 of 6 categories
FORR leads 1 • CSGP leads 0 • VRSK leads 0 • IT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IT is the larger business by revenue, generating $6.5B annually — 16.3x FORR's $397M. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to FORR's -30.1%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $397M | $3.4B | $3.1B | $6.5B | $3.1B |
| EBITDAEarnings before interest/tax | -$66M | $278M | $1.7B | $1.3B | $2.0B |
| Net IncomeAfter-tax profit | -$119M | $25M | $910M | $741M | $1.3B |
| Free Cash FlowCash after capex | $18M | $241M | $1.1B | $1.3B | $1.5B |
| Gross MarginGross profit ÷ Revenue | +64.6% | +77.4% | +67.4% | +68.2% | +82.4% |
| Operating MarginEBIT ÷ Revenue | -20.9% | -0.8% | +44.9% | +16.4% | +54.7% |
| Net MarginNet income ÷ Revenue | -30.1% | +0.7% | +29.3% | +11.4% | +38.4% |
| FCF MarginFCF ÷ Revenue | +4.6% | +7.1% | +36.3% | +19.4% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.5% | +22.5% | +3.9% | -1.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -79.1% | +127.7% | +4.8% | +17.3% | +49.1% |
Valuation Metrics
FORR leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 16.4x trailing earnings, IT trades at a 99% valuation discount to CSGP's 2107.2x P/E. Adjusting for growth (PEG ratio), IT offers better value at 0.61x vs VRSK's 3.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $125M | $14.8B | $22.9B | $10.6B | $42.8B |
| Enterprise ValueMkt cap + debt − cash | $134M | $14.2B | $25.7B | $12.5B | $48.6B |
| Trailing P/EPrice ÷ TTM EPS | -1.04x | 2107.23x | 26.92x | 16.36x | 37.81x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.54x | 25.84x | 22.85x | 11.94x | 29.99x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.16x | 0.61x | 2.23x |
| EV / EBITDAEnterprise value multiple | 8.00x | 83.74x | 15.34x | 10.17x | 25.17x |
| Price / SalesMarket cap ÷ Revenue | 0.32x | 4.57x | 7.45x | 1.63x | 13.67x |
| Price / BookPrice ÷ Book value/share | 0.98x | 1.77x | 78.44x | 35.58x | — |
| Price / FCFMarket cap ÷ FCF | 6.92x | 361.59x | 19.20x | 8.99x | 27.65x |
Profitability & Efficiency
MSCI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-81 for FORR. CSGP carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), MSCI scores 8/9 vs FORR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -80.8% | +0.3% | +4.4% | +119.8% | — |
| ROA (TTM)Return on assets | -28.2% | +0.2% | +16.7% | +9.5% | +24.0% |
| ROICReturn on invested capital | +0.8% | -0.9% | +33.0% | +33.9% | +34.9% |
| ROCEReturn on capital employed | +0.8% | -0.8% | +39.6% | +23.9% | +44.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 5 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.57x | 0.14x | 16.26x | 11.31x | — |
| Net DebtTotal debt minus cash | $9M | -$589M | $2.9B | $1.9B | $5.8B |
| Cash & Equiv.Liquid assets | $63M | $1.7B | $2.2B | $1.7B | $515M |
| Total DebtShort + long-term debt | $72M | $1.1B | $5.0B | $3.6B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | -30.30x | 1.58x | 7.87x | 15.64x | 7.67x |
Total Returns (Dividends Reinvested)
MSCI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSCI five years ago would be worth $12,792 today (with dividends reinvested), compared to $1,413 for FORR. Over the past 12 months, MSCI leads with a +7.8% total return vs IT's -63.9%. The 3-year compound annual growth rate (CAGR) favors MSCI at 8.7% vs FORR's -36.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -19.9% | -46.7% | -20.7% | -33.4% | +4.5% |
| 1-Year ReturnPast 12 months | -35.7% | -53.6% | -43.0% | -63.9% | +7.8% |
| 3-Year ReturnCumulative with dividends | -74.5% | -52.9% | -14.5% | -48.1% | +28.6% |
| 5-Year ReturnCumulative with dividends | -85.9% | -58.9% | +1.8% | -32.5% | +27.9% |
| 10-Year ReturnCumulative with dividends | -75.9% | +77.5% | +137.1% | +64.6% | +720.9% |
| CAGR (3Y)Annualised 3-year return | -36.6% | -22.2% | -5.1% | -19.6% | +8.7% |
Risk & Volatility
Evenly matched — VRSK and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than IT's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 93.9% from its 52-week high vs IT's 34.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 0.80x | -0.04x | 0.94x | 0.61x |
| 52-Week HighHighest price in past year | $11.57 | $97.43 | $322.92 | $451.73 | $626.28 |
| 52-Week LowLowest price in past year | $4.88 | $33.31 | $161.70 | $139.18 | $501.08 |
| % of 52W HighCurrent price vs 52-week peak | +56.4% | +35.9% | +54.1% | +34.9% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 51.6 | 30.4 | 39.5 | 47.7 | 54.6 |
| Avg Volume (50D)Average daily shares traded | 109K | 5.9M | 1.9M | 1.5M | 520K |
Analyst Outlook
MSCI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FORR as "Hold", CSGP as "Buy", VRSK as "Hold", IT as "Hold", MSCI as "Buy". Consensus price targets imply 77.0% upside for CSGP (target: $62) vs 14.6% for MSCI (target: $674). For income investors, MSCI offers the higher dividend yield at 1.22% vs VRSK's 1.03%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $61.91 | $231.25 | $189.30 | $674.33 |
| # AnalystsCovering analysts | 4 | 25 | 25 | 18 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.0% | — | +1.2% |
| Dividend StreakConsecutive years of raises | 6 | — | 7 | 2 | 11 |
| Dividend / ShareAnnual DPS | — | — | $1.81 | — | $7.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +3.9% | +2.7% | +18.8% | +5.8% |
MSCI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FORR leads in 1 (Valuation Metrics). 1 tied.
FORR vs CSGP vs VRSK vs IT vs MSCI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORR or CSGP or VRSK or IT or MSCI a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus -8. 2% for Forrester Research, Inc. (FORR). Gartner, Inc. (IT) offers the better valuation at 16. 4x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORR or CSGP or VRSK or IT or MSCI?
On trailing P/E, Gartner, Inc.
(IT) is the cheapest at 16. 4x versus CoStar Group, Inc. at 2107. 2x. On forward P/E, Forrester Research, Inc. is actually cheaper at 8. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Gartner, Inc. wins at 0. 45x versus Verisk Analytics, Inc. 's 2. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FORR or CSGP or VRSK or IT or MSCI?
Over the past 5 years, MSCI Inc.
(MSCI) delivered a total return of +27. 9%, compared to -85. 9% for Forrester Research, Inc. (FORR). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus FORR's -75. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORR or CSGP or VRSK or IT or MSCI?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 04β versus Gartner, Inc. 's 0. 94β — meaning IT is approximately -2704% more volatile than VRSK relative to the S&P 500. On balance sheet safety, CoStar Group, Inc. (CSGP) carries a lower debt/equity ratio of 14% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORR or CSGP or VRSK or IT or MSCI?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus -8. 2% for Forrester Research, Inc. (FORR). On earnings-per-share growth, the picture is similar: MSCI Inc. grew EPS 10. 7% year-over-year, compared to -1993. 3% for Forrester Research, Inc.. Over a 3-year CAGR, CSGP leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORR or CSGP or VRSK or IT or MSCI?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus -30. 1% for Forrester Research, Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus -2. 2% for CSGP. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORR or CSGP or VRSK or IT or MSCI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Gartner, Inc. (IT) is the more undervalued stock at a PEG of 0. 45x versus Verisk Analytics, Inc. 's 2. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Forrester Research, Inc. (FORR) trades at 8. 5x forward P/E versus 30. 0x for MSCI Inc. — 21. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 77. 0% to $61. 91.
08Which pays a better dividend — FORR or CSGP or VRSK or IT or MSCI?
In this comparison, MSCI (1.
2% yield), VRSK (1. 0% yield) pay a dividend. FORR, CSGP, IT do not pay a meaningful dividend and should not be held primarily for income.
09Is FORR or CSGP or VRSK or IT or MSCI better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). Both have compounded well over 10 years (VRSK: +137. 1%, IT: +64. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORR and CSGP and VRSK and IT and MSCI?
These companies operate in different sectors (FORR (Industrials) and CSGP (Real Estate) and VRSK (Industrials) and IT (Technology) and MSCI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORR is a small-cap quality compounder stock; CSGP is a mid-cap high-growth stock; VRSK is a mid-cap quality compounder stock; IT is a mid-cap deep-value stock; MSCI is a mid-cap quality compounder stock. VRSK, MSCI pay a dividend while FORR, CSGP, IT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.